Antisoma Plans to List its Shares in the United States
April 04, 2005 02:16 ET
|
Antisoma plc
LONDON, April 4, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) announces today that it intends to list its shares on NASDAQ. As an interim step, the Company will establish a Level...
Antisoma and Raylo Sign Major Manufacturing Deal for AS1411
March 14, 2005 02:10 ET
|
Antisoma plc
LONDON and EDMONTON, Alberta, Canada, March 14, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) announces that it has signed an agreement with Raylo Chemicals of Edmonton, Alberta,...
Antisoma to Present at SG Cowen Conference on March 17
March 10, 2005 08:16 ET
|
Antisoma plc
LONDON, March 10, 2005 (PRIMEZONE) -- Antisoma plc (LSE: ASM) today announces that Chief Executive Officer, Glyn Edwards, will be presenting at the 25th SG Cowen Annual Healthcare conference, Boston,...
Antisoma plc reports H1 results
February 16, 2005 02:26 ET
|
Antisoma plc
LONDON, Feb. 16, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) today announces its interim results for the period ended 31 December 2004.
Highlights
- Acquisition of U.S....
Antisoma completes acquisition of Aptamera
February 04, 2005 03:11 ET
|
Antisoma plc
LOUISVILLE, Ken. and LONDON, Feb. 4, 2005 (PRIMEZONE) -- Further to the announcement made yesterday, Antisoma plc (LSE:ASM) announces the completion of its acquisition of Aptamera Inc. This follows...
Aptamera's Shareholders Approve Acquisition by Antisoma
February 03, 2005 02:12 ET
|
Antisoma plc
LONDON and LOUISVILLE, Ken., Feb. 3, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) announces that the shareholders of Aptamera Inc yesterday approved Antisoma's acquisition of...
Acquisition: UK cancer specialist Antisoma to acquire U.S. cancer company Aptamera
January 10, 2005 02:10 ET
|
Antisoma plc
LOUISVILLE, Ken. and LONDON, Jan. 10, 2005 (PRIMEZONE) -- Acquisition will add promising clinical product AGRO100 to Antisoma's pipeline
Cancer drug development company Antisoma plc (LSE:ASM)...
Antisoma AGM Update
November 23, 2004 02:24 ET
|
Antisoma plc
LONDON, Nov. 23, 2004 (PRIMEZONE) -- Speaking at today's Annual General Meeting of Antisoma plc (LSE:ASM), Chairman Dr. Barry Price will review progress in the Company's pipeline of cancer drugs and...
Antisoma Telomere Targeting Agent Stops Tumour Growth In Prostate Cancer Model
November 04, 2004 02:12 ET
|
Antisoma plc
LONDON, Nov. 4, 2004 (PRIMEZONE) -- Cancer drug developer Antisoma today presents new data showing that one of its telomere targeting agents (TTAs) rapidly blocks prostate tumour growth in a human...
New lymphoma data support Antisoma's plans for AS1406
October 06, 2004 02:10 ET
|
Antisoma plc
LONDON, Oct. 6, 2004 (PRIMEZONE) -- Cancer drug development company Antisoma plc (LSE:ASM) will today present further promising data for its targeted apoptosis drug AS1406. Speaking at the Human...